Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Heterozygous missense variants in VCL have been reported in unrelated individuals with Hypertrophic Cardiomyopathy in the absence of known sarcomeric gene mutations. In a cohort of 228 genotype‐negative HCM patients, a novel c.829C>A (p.Leu277Met) variant was identified in one patient with severe mid‐ventricular obstruction and absent in 400 reference alleles (PMID:16712796). In a separate screen of 389 HCM probands, three additional missense changes (p.Ala934Val, p.Pro943Ala, p.Arg975Trp) were found in four patients but showed no robust pedigree segregation (PMID:16236538). No affected relatives with segregating VCL variants have been reported.
Functional studies support a pathogenic role for VCL variants in cardiac muscle remodeling. Immunohistochemistry of myectomy tissue from variant carriers reveals reduced vinculin at intercalated discs (PMID:16712796). In vitro assays and molecular modeling demonstrate that mutations in the metavinculin tail domain (e.g., p.Arg975Trp) disrupt F‐actin bundling and dimerization, leading to aberrant cytoskeletal assemblies consistent with hypertrophic remodeling (PMID:30844403). Deep‐intronic VCL variants have also been prioritized in HCM cohorts, though co‐segregation and functional validation remain limited (PMID:28797094).
Overall, the association between VCL and HCM is classified as Limited based on five unrelated probands, absence of segregation data, and supportive but non‐definitive functional evidence. Key take-home: VCL genetic testing may uncover rare risk alleles in HCM, but interpretation requires caution due to limited case numbers and lack of familial segregation.
Gene–Disease AssociationLimitedFive unrelated probands (c.829C>A, p.Leu277Met; p.Ala934Val; p.Pro943Ala; p.Arg975Trp) with HCM, no segregation data, supportive functional assays Genetic EvidenceLimitedCase‐level data in 5 probands, absence of family segregation Functional EvidenceModerateImmunohistochemistry and in vitro F‐actin bundling assays concordantly demonstrate functional impact of VCL variants |